Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans

Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, Aki Havulinna, Rachel M. Y. Ong, Tibor Kempf, Kai C. Wollert, Stefan Blankenberg, Tanja Zeller, James E. Peters, Veikko Salomaa, Maria Fritsch, Ruth March, Aarno Palotie, Mark Daly, Adam S. Butterworth, Mervi Kinnunen, Dirk S. Paul, Athena Matakidou
doi: https://doi.org/10.1101/2021.12.15.21267719

Article Information

doi 
https://doi.org/10.1101/2021.12.15.21267719
History 
  • December 16, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Susanna Lemmelä1,*,
  2. Eleanor M. Wigmore2,*,#,
  3. Christian Benner1,
  4. Aki Havulinna1,3,
  5. Rachel M. Y. Ong4,
  6. Tibor Kempf5,
  7. Kai C. Wollert5,
  8. Stefan Blankenberg6,
  9. Tanja Zeller6,
  10. James E. Peters7,8,
  11. Veikko Salomaa3,
  12. Maria Fritsch9,
  13. Ruth March10,
  14. Aarno Palotie1,11,12,
  15. Mark Daly1,11,12,
  16. Adam S. Butterworth4,8,13,14,
  17. Mervi Kinnunen1,
  18. Dirk S. Paul2,4,13 and
  19. Athena Matakidou2
  1. 1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
  2. 2Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
  3. 3Finnish Institute for Health and Welfare, Helsinki, Finland
  4. 4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
  5. 5Department of Cardiology and Angiology, Hannover Medical School, Germany
  6. 6Clinic for General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
  7. 7Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK
  8. 8Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
  9. 9Bioscience Renal, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
  10. 10Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, UK
  11. 11Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
  12. 12Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
  13. 13British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
  14. 14National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
  1. ↵#Corresponding author; email: eleanor.wigmore{at}astrazeneca.com
Back to top
Posted December 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans
Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, Aki Havulinna, Rachel M. Y. Ong, Tibor Kempf, Kai C. Wollert, Stefan Blankenberg, Tanja Zeller, James E. Peters, Veikko Salomaa, Maria Fritsch, Ruth March, Aarno Palotie, Mark Daly, Adam S. Butterworth, Mervi Kinnunen, Dirk S. Paul, Athena Matakidou
medRxiv 2021.12.15.21267719; doi: https://doi.org/10.1101/2021.12.15.21267719
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area